Food News and Research

RSS

Liraglutide FDA feedback expected within weeks, says Novo Nordisk

Novo Nordisk today announced that formal feedback from the United States Food and Drug Administration (FDA) regarding liraglutide, a once-daily human GLP-1 analogue, is expected within weeks.

30 Dec 2009

Chlorophyll and chlorophyllin effective in limiting aflatoxin absorption in humans

A new study has found that chlorophyll and its derivative chlorophyllin are effective in limiting the absorption of aflatoxin in humans. Aflatoxin is produced by a fungus that is a contaminant of grains including corn, peanuts and soybeans; it is known to cause liver cancer - and can work in concert with other health concerns, such as hepatitis.

30 Dec 2009

Fred Pritzker calls on meat suppliers to pay medical bills incurred by victims of E. coli

National food safety lawyer Fred Pritzker is calling on National Steak and Poultry company to immediately pay all medical bills and lost wages incurred by victims of a multi-state outbreak of E. coli O157:H7 associated with blade-tenderized steaks.

30 Dec 2009

Spectranetics reports settlement of matters related to federal investigation

Spectranetics Corporation (“Company”) today reported the settlement of matters related to the federal investigation initiated by the Food & Drug Administration and U.S. Immigration and Customs Enforcement, which was previously announced in a press release dated September 4, 2008.

30 Dec 2009

Majority of Americans fail at keeping their New Years resolutions to lose weight and get in shape

Nutritionist Judy Pentra, of Patients Medical, a multi-specialty wellness center in New York, warns that the New Year can be a vulnerable time for people trying to lose weight and get in shape. The average person can gain 2-5 pounds during the holidays and many resolve to lose the weight in January, however, 70 percent of Americans fail at keeping their New Years resolutions.

30 Dec 2009

CORE, a biopsychosocial treatment center for weight loss

Earlier this month, leaders in the treatment of weight related disorders and psychiatry joined forces under the Comprehensive Obesity Recovery Effort (CORE, LLC).

30 Dec 2009

FDA impersonators threaten and extort victims who purchase drugs over the Internet

The U.S. Food and Drug Administration is warning the public about criminals posing as FDA special agents and other law enforcement personnel as part of an international extortion scam.

30 Dec 2009

Majority of small business owners do not support public health care option

Eighty-three percent of the owners of small businesses surveyed across Michigan do not support a government-operated health care plan as a public option for insurance, according to a new survey of the members of the Michigan Business and Professional Association (MBPA) and the Michigan Food and Beverage Association (MFBA) headquartered in Warren. This is intriguing data as Michigan's economy has been under national scrutiny and the bills were designed to help small business.

30 Dec 2009

Spectranetics illegally imports unapproved medical devices, agrees to pay $5M for resolving allegations

Spectranetics Corporation, a medical device manufacturer, has agreed to pay the United States $4.9 million in civil damages plus a $100,000 forfeiture to resolve claims against the company, the Justice Department announced today. The claims arise from allegations that the company illegally imported unapproved medical devices and provided them to physicians for use in patients, conducted a clinical study in a manner that failed to comply with federal regulations and promoted certain products for procedures for which the company had not received Food and Drug Administration approval or clearance.

30 Dec 2009

VIVUS submits a NDA to the FDA for obesity drug Qnexa

VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.

30 Dec 2009

Pre-market approval by FDA of cardiovascular devices often based on studies that lack adequate strength

Pre-market approval by the FDA of cardiovascular devices is often based on studies that lack adequate strength or may have been prone to bias, according to a study in the December 23/30 issue of JAMA. The researchers found that of nearly 80 high-risk devices, the majority received approval based on data from a single study.

29 Dec 2009

Food Safety News lists its top ten ten food safety stories of 2009

Food Safety News, the web-based newspaper that covers all things food safety, today published its list of the top ten food safety stories of the year.

29 Dec 2009

NSP recalls E. coli contaminated beef steaks in six states

On Christmas eve the Food Safety and Inspection Service (FSIS) issued a notice that National Steak and Poultry (NSP) was recalling 248,000 pounds of beef steaks contaminated with the highly virulent pathogen E. coli O157:H7. The steaks were mechanically tenderized “non-intact steaks”, and were shipped to restaurants nationwide.

29 Dec 2009

Study suggests genetic variations predispose African-Americans to diabetes

For years, scientists have tried to determine the basis for discrepancies between race and the predisposition for development of diseases such as type II diabetes and cardiovascular disease. Could factors such as differences in lifestyle or access to health care play a role, or is there something else in play?

29 Dec 2009

First animal model for studying schizophrenia

Scientists have created what appears to be a schizophrenic mouse by reducing the inhibition of brain cells involved in complex reasoning and decisions about appropriate social behavior.

29 Dec 2009

Smart for Life introduces new THIN ADVENTURE Children's Weight Loss Program

With many American children overweight and obese, Smart for Life's new THIN ADVENTURE(TM) Children's Weight Loss Program introduces an affordable 30-day weight-loss program designed for children between the ages of 6 and 14. It will be available at http://www.smartforlife.com and other affiliated retailers in January 2010.

29 Dec 2009

Cholesterol expert offers simple resolutions and advice for staying heart healthy in New Year

Family physician and cholesterol expert Michael Cobble, M.D., has some simple resolutions and fun advice for staying heart healthy in the new year. Cobble is a board-certified clinical lipidologist (NLA), certified hypertension specialist (ASH), medical director of the private practice Canyons Medical Center in Sandy, Utah, and Chief Medical Officer at Atherotech, Inc., developer of the VAP Cholesterol Test.

29 Dec 2009

Nutrient-rich foods for weight loss

For the majority of Americans who are unhappy with their weight at any given moment, the New Year brings mixed emotions: the renewed resolution to shed pounds and the challenge of learning how to eat right to reach those goals.

29 Dec 2009

SVA submits the first clinical trial application for HFMD vaccine in China

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today that it has filed the application with China's State Food and Drug Administration (SFDA) to commence a human clinical trial for its vaccine against human enterovirus 71 (EV 71), which causes hand, foot, and mouth disease (HFMD). This is the first clinical trial application for HFMD vaccine submitted in China.

28 Dec 2009

Aeolus Pharmaceuticals reports financial results for three months and twelve months ended September 30, 2009

Aeolus Pharmaceuticals, Inc. announced today financial results for the three months and twelve months ended September 30, 2009. The Company reported a net loss of $746,000, or $0.02 per share, for the three months ended September 30, 2009 compared to a loss of $1,055,000, or $0.03 per share, for the three months ended September 30, 2008.

28 Dec 2009

Food News and Research

Liraglutide FDA feedback expected within weeks, says Novo Nordisk

Chlorophyll and chlorophyllin effective in limiting aflatoxin absorption in humans

Fred Pritzker calls on meat suppliers to pay medical bills incurred by victims of E. coli

Spectranetics reports settlement of matters related to federal investigation

Majority of Americans fail at keeping their New Years resolutions to lose weight and get in shape

CORE, a biopsychosocial treatment center for weight loss

FDA impersonators threaten and extort victims who purchase drugs over the Internet

Majority of small business owners do not support public health care option

Spectranetics illegally imports unapproved medical devices, agrees to pay $5M for resolving allegations

VIVUS submits a NDA to the FDA for obesity drug Qnexa

Pre-market approval by FDA of cardiovascular devices often based on studies that lack adequate strength

Food Safety News lists its top ten ten food safety stories of 2009

NSP recalls E. coli contaminated beef steaks in six states

Study suggests genetic variations predispose African-Americans to diabetes

First animal model for studying schizophrenia

Smart for Life introduces new THIN ADVENTURE Children's Weight Loss Program

Cholesterol expert offers simple resolutions and advice for staying heart healthy in New Year

Nutrient-rich foods for weight loss

SVA submits the first clinical trial application for HFMD vaccine in China

Aeolus Pharmaceuticals reports financial results for three months and twelve months ended September 30, 2009

Enhancing confidence in chemical ionization spectrometry data eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News